David Roman
Stock Analyst at Goldman Sachs
(2.77)
# 1,754
Out of 5,111 analysts
59
Total ratings
42.42%
Success rate
0.42%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KMTS Kestra Medical Technologies | Maintains: Neutral | $22 → $25 | $27.36 | -8.63% | 3 | Dec 15, 2025 | |
| COO The Cooper Companies | Maintains: Sell | $64 → $71 | $80.39 | -11.68% | 2 | Dec 8, 2025 | |
| MDT Medtronic | Upgrades: Neutral | $81 → $111 | $97.29 | +14.09% | 2 | Nov 19, 2025 | |
| IRTC iRhythm Technologies | Maintains: Neutral | $180 → $202 | $168.61 | +19.80% | 4 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $94 → $104 | $84.72 | +22.76% | 4 | Oct 31, 2025 | |
| BAX Baxter International | Maintains: Neutral | $25 → $22 | $18.84 | +16.77% | 4 | Oct 31, 2025 | |
| BBNX Beta Bionics | Maintains: Buy | $26 → $33 | $28.91 | +14.15% | 3 | Oct 29, 2025 | |
| BLCO Bausch + Lomb | Initiates: Neutral | $16 | $16.92 | -5.41% | 1 | Oct 1, 2025 | |
| GKOS Glaukos | Initiates: Buy | $103 | $112.77 | -8.66% | 1 | Oct 1, 2025 | |
| DOCS Doximity | Downgrades: Sell | $57 → $64 | $43.71 | +46.42% | 4 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $16.39 | +22.03% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $12.50 | +52.00% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $14.46 | +100.55% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $104 | $95.73 | +8.64% | 3 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $380 | $288.13 | +31.88% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $90.50 | +14.92% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $7.31 | +36.80% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $81.98 | +0.02% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $126.48 | +21.76% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $22.30 | +7.62% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $80.35 | -11.64% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $62.88 | -12.53% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $350.33 | +21.89% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $92.09 | -2.26% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $546.64 | -8.53% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $195.41 | +40.22% | 1 | May 30, 2024 |
Kestra Medical Technologies
Dec 15, 2025
Maintains: Neutral
Price Target: $22 → $25
Current: $27.36
Upside: -8.63%
The Cooper Companies
Dec 8, 2025
Maintains: Sell
Price Target: $64 → $71
Current: $80.39
Upside: -11.68%
Medtronic
Nov 19, 2025
Upgrades: Neutral
Price Target: $81 → $111
Current: $97.29
Upside: +14.09%
iRhythm Technologies
Oct 31, 2025
Maintains: Neutral
Price Target: $180 → $202
Current: $168.61
Upside: +19.80%
Edwards Lifesciences
Oct 31, 2025
Maintains: Buy
Price Target: $94 → $104
Current: $84.72
Upside: +22.76%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $25 → $22
Current: $18.84
Upside: +16.77%
Beta Bionics
Oct 29, 2025
Maintains: Buy
Price Target: $26 → $33
Current: $28.91
Upside: +14.15%
Bausch + Lomb
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $16.92
Upside: -5.41%
Glaukos
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $112.77
Upside: -8.66%
Doximity
Oct 1, 2025
Downgrades: Sell
Price Target: $57 → $64
Current: $43.71
Upside: +46.42%
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $16.39
Upside: +22.03%
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $12.50
Upside: +52.00%
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $14.46
Upside: +100.55%
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $95.73
Upside: +8.64%
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $288.13
Upside: +31.88%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $90.50
Upside: +14.92%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $7.31
Upside: +36.80%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $81.98
Upside: +0.02%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $126.48
Upside: +21.76%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $22.30
Upside: +7.62%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $80.35
Upside: -11.64%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $62.88
Upside: -12.53%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $350.33
Upside: +21.89%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $92.09
Upside: -2.26%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $546.64
Upside: -8.53%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $195.41
Upside: +40.22%